Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Cerebrovascular Disorders

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 84 articles:
HTML format



Single Articles


    June 2022
  1. MAI H, Chen T, Chen F
    Intra-arterial Alteplase vs Placebo After Successful Thrombectomy and Functional Outcomes in Patients With Large Vessel Occlusion Acute Ischemic Stroke.
    JAMA. 2022;327:2455-2456.
    PubMed    


  2. KIRSHNER HS
    The Concept of Transient Ischemic Attack.
    JAMA. 2022;327:2456-2457.
    PubMed    


  3. CHAMORRO A, Torres F
    Intra-arterial Alteplase vs Placebo After Successful Thrombectomy and Functional Outcomes in Patients With Large Vessel Occlusion Acute Ischemic Stroke-Reply.
    JAMA. 2022;327:2456.
    PubMed    


  4. EASTON JD, Johnston SC
    The Concept of Transient Ischemic Attack-Reply.
    JAMA. 2022;327:2457.
    PubMed    


  5. FRONTERA JA, Ahuja T
    Recent Use of Non-Vitamin K Antagonist Oral Anticoagulants and Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With Alteplase.
    JAMA. 2022;327:2354.
    PubMed    


  6. WEBB AJ, Brown CS, Rech MA
    Recent Use of Non-Vitamin K Antagonist Oral Anticoagulants and Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With Alteplase.
    JAMA. 2022;327:2354-2355.
    PubMed    


  7. KAM W, Xian Y
    Recent Use of Non-Vitamin K Antagonist Oral Anticoagulants and Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With Alteplase-Reply.
    JAMA. 2022;327:2355.
    PubMed    


    May 2022
  8. CHANG RW, Tucker LY, Rothenberg KA, Lancaster E, et al
    Incidence of Ischemic Stroke in Patients With Asymptomatic Severe Carotid Stenosis Without Surgical Intervention.
    JAMA. 2022;327:1974-1982.
    PubMed     Abstract available


  9. ZACHRISON KS, Schwamm LH
    Strategic Opportunities to Improve Stroke Systems of Care.
    JAMA. 2022 May 5. pii: 2791845. doi: 10.1001/jama.2022.3820.
    PubMed    


  10. PEREZ DE LA OSSA N, Abilleira S, Jovin TG, Garcia-Tornel A, et al
    Effect of Direct Transportation to Thrombectomy-Capable Center vs Local Stroke Center on Neurological Outcomes in Patients With Suspected Large-Vessel Occlusion Stroke in Nonurban Areas: The RACECAT Randomized Clinical Trial.
    JAMA. 2022 May 5. pii: 2791844. doi: 10.1001/jama.2022.4404.
    PubMed     Abstract available


  11. HUBERT GJ, Hubert ND, Maegerlein C, Kraus F, et al
    Association Between Use of a Flying Intervention Team vs Patient Interhospital Transfer and Time to Endovascular Thrombectomy Among Patients With Acute Ischemic Stroke in Nonurban Germany.
    JAMA. 2022 May 5. pii: 2791843. doi: 10.1001/jama.2022.5948.
    PubMed     Abstract available


  12. BOSEL J, Niesen WD, Salih F, Morris NA, et al
    Effect of Early vs Standard Approach to Tracheostomy on Functional Outcome at 6 Months Among Patients With Severe Stroke Receiving Mechanical Ventilation: The SETPOINT2 Randomized Clinical Trial.
    JAMA. 2022 May 4. pii: 2792016. doi: 10.1001/jama.2022.4798.
    PubMed     Abstract available


    April 2022
  13. DAVIDSON KW, Barry MJ, Mangione CM, Cabana M, et al
    Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2022;327:1577-1584.
    PubMed     Abstract available


  14. RIGATELLI G, Zuin M
    Treatment Effects in Analysis of Pooled Individual Patient Data From Randomized Trials of Device Closure of Patent Foramen Ovale.
    JAMA. 2022;327:1403.
    PubMed    


  15. KENT DM, Saver JL, Thaler DE
    Treatment Effects in Analysis of Pooled Individual Patient Data From Randomized Trials of Device Closure of Patent Foramen Ovale-Reply.
    JAMA. 2022;327:1403.
    PubMed    


  16. GU HQ
    Rivaroxaban vs Apixaban and Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation.
    JAMA. 2022;327:1290.
    PubMed    


  17. RAY WA, Murray KT
    Rivaroxaban vs Apixaban and Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation-Reply.
    JAMA. 2022;327:1290.
    PubMed    


    March 2022
  18. PRABHAKARAN S, Greenland P
    Role of the Heart in Dementia Etiology in the Absence of Atrial Fibrillation or Stroke.
    JAMA. 2022;327:1133-1134.
    PubMed    


  19. WALTER K
    What Is Acute Ischemic Stroke?
    JAMA. 2022;327:885.
    PubMed    


  20. EASTON JD, Johnston SC
    Time to Retire the Concept of Transient Ischemic Attack.
    JAMA. 2022;327:813-814.
    PubMed    


    February 2022
  21. SURAN M
    Highlights From the International Stroke Conference 2022-Thrombectomy and Alteplase, Access to Stroke Centers, and Warfarin vs Direct Oral Anticoagulants.
    JAMA. 2022 Feb 23. pii: 2789530. doi: 10.1001/jama.2022.2096.
    PubMed    


  22. RENU A, Millan M, San Roman L, Blasco J, et al
    Effect of Intra-arterial Alteplase vs Placebo Following Successful Thrombectomy on Functional Outcomes in Patients With Large Vessel Occlusion Acute Ischemic Stroke: The CHOICE Randomized Clinical Trial.
    JAMA. 2022 Feb 10. pii: 2789098. doi: 10.1001/jama.2022.1645.
    PubMed     Abstract available


  23. SEIFFGE DJ
    Intravenous Thrombolytic Therapy for Treatment of Acute Ischemic Stroke in Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants.
    JAMA. 2022 Feb 10. pii: 2789100. doi: 10.1001/jama.2022.0068.
    PubMed    


  24. KAM W, Holmes DN, Hernandez AF, Saver JL, et al
    Association of Recent Use of Non-Vitamin K Antagonist Oral Anticoagulants With Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With Alteplase.
    JAMA. 2022 Feb 10. pii: 2789099. doi: 10.1001/jama.2022.0948.
    PubMed     Abstract available


  25. SLOMSKI A
    Strokes Occur Later and Are Less Severe Than 2 Decades Ago.
    JAMA. 2022;327:416.
    PubMed    


  26. LEVY B, Girerd N, Amour J, Besnier E, et al
    Effect of Moderate Hypothermia vs Normothermia on 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial Extracorporeal Membrane Oxygenation: A Randomized Clinical Trial.
    JAMA. 2022;327:442-453.
    PubMed     Abstract available


    January 2022
  27. GREENLAND P
    Screening for Atrial Fibrillation-More Data Still Needed.
    JAMA. 2022;327:329-330.
    PubMed    


  28. JIN J
    Screening for Atrial Fibrillation.
    JAMA. 2022;327:401.
    PubMed    


  29. KAHWATI LC, Asher GN, Kadro ZO, Keen S, et al
    Screening for Atrial Fibrillation: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2022;327:368-383.
    PubMed     Abstract available


  30. DAVIDSON KW, Barry MJ, Mangione CM, Cabana M, et al
    Screening for Atrial Fibrillation: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2022;327:360-367.
    PubMed     Abstract available


  31. BELL EF, Hintz SR, Hansen NI, Bann CM, et al
    Mortality, In-Hospital Morbidity, Care Practices, and 2-Year Outcomes for Extremely Preterm Infants in the US, 2013-2018.
    JAMA. 2022;327:248-263.
    PubMed     Abstract available


    December 2021
  32. RAY WA, Chung CP, Stein CM, Smalley W, et al
    Association of Rivaroxaban vs Apixaban With Major Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation.
    JAMA. 2021;326:2395-2404.
    PubMed     Abstract available


  33. KENT DM, Saver JL, Kasner SE, Nelson J, et al
    Heterogeneity of Treatment Effects in an Analysis of Pooled Individual Patient Data From Randomized Trials of Device Closure of Patent Foramen Ovale After Stroke.
    JAMA. 2021;326:2277-2286.
    PubMed     Abstract available


    November 2021
  34. JABAGI MJ, Botton J, Bertrand M, Weill A, et al
    Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older.
    JAMA. 2021 Nov 22. pii: 2786667. doi: 10.1001/jama.2021.21699.
    PubMed    


    October 2021
  35. ITO H
    Implantable vs Prolonged External Electrocardiographic Monitoring for Atrial Fibrillation Detection in Patients With Ischemic Stroke.
    JAMA. 2021;326:1439.
    PubMed    


  36. BUCK BH, Hill MD, Exner DV
    Implantable vs Prolonged External Electrocardiographic Monitoring for Atrial Fibrillation Detection in Patients With Ischemic Stroke-Reply.
    JAMA. 2021;326:1439-1440.
    PubMed    


  37. SUOLANG D, Chen BJ, Wang NY, Gottesman RF, et al
    Temporal Trends in Stroke Thrombolysis in the US by Race and Ethnicity, 2009-2018.
    JAMA. 2021 Oct 11. pii: 2785219. doi: 10.1001/jama.2021.12966.
    PubMed    


  38. VOELKER R
    A First in Stroke Rehabilitation.
    JAMA. 2021;326:1247.
    PubMed    


    September 2021
  39. LAPERGUE B, Blanc R, Costalat V, Desal H, et al
    Effect of Thrombectomy With Combined Contact Aspiration and Stent Retriever vs Stent Retriever Alone on Revascularization in Patients With Acute Ischemic Stroke and Large Vessel Occlusion: The ASTER2 Randomized Clinical Trial.
    JAMA. 2021;326:1158-1169.
    PubMed     Abstract available


  40. MAKKAR RR, Yoon SH, Chakravarty T, Kapadia SR, et al
    Association Between Transcatheter Aortic Valve Replacement for Bicuspid vs Tricuspid Aortic Stenosis and Mortality or Stroke Among Patients at Low Surgical Risk.
    JAMA. 2021;326:1034-1044.
    PubMed     Abstract available


    July 2021
  41. ORNELLO R, Pistoia F, Sacco S
    The US Preventive Services Task Force Recommendation Statement About Screening Asymptomatic Adults for Carotid Stenosis.
    JAMA. 2021;326:89.
    PubMed    


  42. POORTHUIS MHF, de Borst GJ
    The US Preventive Services Task Force Recommendation Statement About Screening Asymptomatic Adults for Carotid Stenosis.
    JAMA. 2021;326:88-89.
    PubMed    


  43. WOLTERS FJ, Volovici V
    The US Preventive Services Task Force Recommendation Statement About Screening Asymptomatic Adults for Carotid Stenosis.
    JAMA. 2021;326:88.
    PubMed    


  44. BARRY MJ, Davidson K, Mangione CM
    The US Preventive Services Task Force Recommendation Statement About Screening Asymptomatic Adults for Carotid Stenosis-Reply.
    JAMA. 2021;326:89-90.
    PubMed    


  45. SANCHEZ VAN KAMMEN M, Heldner MR, Brodard J, Scutelnic A, et al
    Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.
    JAMA. 2021 Jul 2. pii: 2781791. doi: 10.1001/jama.2021.9889.
    PubMed     Abstract available


  46. LEE M, Ovbiagele B, Saver JL
    Intensive Medical Management to Prevent Large and Small Artery Atherothrombotic Stroke: Time to Expand the Horizon.
    JAMA. 2021 Jul 1. pii: 2781757. doi: 10.1001/jama.2021.9917.
    PubMed    


    June 2021
  47. SLOMSKI A
    Vagus Nerve Stimulation Restores Arm Function Years After Stroke.
    JAMA. 2021;325:2427.
    PubMed    


  48. LISS DT, Uchida T, Wilkes CL, Radakrishnan A, et al
    General Health Checks in Adult Primary Care: A Review.
    JAMA. 2021;325:2294-2306.
    PubMed     Abstract available


  49. SOLOMON MD, Nguyen-Huynh M, Leong TK, Alexander J, et al
    Changes in Patterns of Hospital Visits for Acute Myocardial Infarction or Ischemic Stroke During COVID-19 Surges.
    JAMA. 2021 Jun 2. pii: 2780794. doi: 10.1001/jama.2021.8414.
    PubMed    


  50. TIRSCHWELL D, Akoum N
    Detection of Subclinical Atrial Fibrillation After Stroke: Is There Enough Evidence to Treat?
    JAMA. 2021;325:2157-2159.
    PubMed    


  51. VOELKER R
    Helping Patients Improve Muscle Movement After Stroke.
    JAMA. 2021;325:2143.
    PubMed    


  52. BUCK BH, Hill MD, Quinn FR, Butcher KS, et al
    Effect of Implantable vs Prolonged External Electrocardiographic Monitoring on Atrial Fibrillation Detection in Patients With Ischemic Stroke: The PER DIEM Randomized Clinical Trial.
    JAMA. 2021;325:2160-2168.
    PubMed     Abstract available


  53. BERNSTEIN RA, Kamel H, Granger CB, Piccini JP, et al
    Effect of Long-term Continuous Cardiac Monitoring vs Usual Care on Detection of Atrial Fibrillation in Patients With Stroke Attributed to Large- or Small-Vessel Disease: The STROKE-AF Randomized Clinical Trial.
    JAMA. 2021;325:2169-2177.
    PubMed     Abstract available


    May 2021
  54. YAN C, Li H
    Preliminary Investigation of In situ Thrombus Within Patent Foramen Ovale in Patients With and Without Stroke.
    JAMA. 2021;325:2116-2118.
    PubMed    


  55. MAI H, Chen T, Zhao B
    Functional Outcomes Among Patients With Acute Ischemic Stroke After Mechanical Thrombectomy With or Without Intravenous Thrombolysis.
    JAMA. 2021;325:2019-2020.
    PubMed    


  56. KIMURA K, Otsuka T, Suzuki K
    Functional Outcomes Among Patients With Acute Ischemic Stroke After Mechanical Thrombectomy With or Without Intravenous Thrombolysis-Reply.
    JAMA. 2021;325:2020.
    PubMed    


    April 2021
  57. SEE I, Su JR, Lale A, Woo EJ, et al
    US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021.
    JAMA. 2021 Apr 30. pii: 2779731. doi: 10.1001/jama.2021.7517.
    PubMed     Abstract available


  58. KARRON RA, Key NS, Sharfstein JM
    Assessing a Rare and Serious Adverse Event Following Administration of the Ad26.COV2.S Vaccine.
    JAMA. 2021 Apr 30. pii: 2779732. doi: 10.1001/jama.2021.7637.
    PubMed    


    March 2021
  59. MENDELSON SJ, Prabhakaran S
    Diagnosis and Management of Transient Ischemic Attack and Acute Ischemic Stroke: A Review.
    JAMA. 2021;325:1088-1098.
    PubMed     Abstract available


  60. FRIEDEN TR, Foti KE
    National Initiatives to Prevent Myocardial Infarction and Stroke.
    JAMA. 2021 Mar 12. pii: 2777651. doi: 10.1001/jama.2021.0905.
    PubMed    


    February 2021
  61. BODILSEN J, Nielsen H
    Risk of Spinal Hematoma After Lumbar Puncture-Reply.
    JAMA. 2021;325:788.
    PubMed    


  62. NOBUHARA CK, Berger M
    Risk of Spinal Hematoma After Lumbar Puncture.
    JAMA. 2021;325:787-788.
    PubMed    


  63. XU T, Wang Y, Chen Y
    Risk of Spinal Hematoma After Lumbar Puncture.
    JAMA. 2021;325:787.
    PubMed    


  64. EBINGER M, Siegerink B, Kunz A, Wendt M, et al
    Association Between Dispatch of Mobile Stroke Units and Functional Outcomes Among Patients With Acute Ischemic Stroke in Berlin.
    JAMA. 2021;325:454-466.
    PubMed     Abstract available


  65. BACHE KG, Grotta JC
    Improving Stroke Treatment and Outcomes With Mobile Stroke Units.
    JAMA. 2021;325:441-442.
    PubMed    


  66. GOLDSTEIN LB
    Screening for Asymptomatic Carotid Artery Stenosis: Lack of Clinical Benefit, Potential for Harm.
    JAMA. 2021;325:443-444.
    PubMed    


  67. KRIST AH, Davidson KW, Mangione CM, Barry MJ, et al
    Screening for Asymptomatic Carotid Artery Stenosis: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2021;325:476-481.
    PubMed     Abstract available


  68. JIN J
    Screening for Carotid Artery Stenosis.
    JAMA. 2021;325:500.
    PubMed    


  69. GUIRGUIS-BLAKE JM, Webber EM, Coppola EL
    Screening for Asymptomatic Carotid Artery Stenosis in the General Population: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2021;325:487-489.
    PubMed    


    January 2021
  70. LIOUTAS VA, Ivan CS, Himali JJ, Aparicio HJ, et al
    Incidence of Transient Ischemic Attack and Association With Long-term Risk of Stroke.
    JAMA. 2021;325:373-381.
    PubMed     Abstract available


  71. ZI W, Qiu Z, Li F, Sang H, et al
    Effect of Endovascular Treatment Alone vs Intravenous Alteplase Plus Endovascular Treatment on Functional Independence in Patients With Acute Ischemic Stroke: The DEVT Randomized Clinical Trial.
    JAMA. 2021;325:234-243.
    PubMed     Abstract available


  72. SUZUKI K, Matsumaru Y, Takeuchi M, Morimoto M, et al
    Effect of Mechanical Thrombectomy Without vs With Intravenous Thrombolysis on Functional Outcome Among Patients With Acute Ischemic Stroke: The SKIP Randomized Clinical Trial.
    JAMA. 2021;325:244-253.
    PubMed     Abstract available


  73. SAVER JL, Adeoye O
    Intravenous Thrombolysis Before Endovascular Thrombectomy for Acute Ischemic Stroke.
    JAMA. 2021;325:229-231.
    PubMed    


  74. SIONTIS KC, Gersh BJ, Chamberlain AM
    Postoperative Atrial Fibrillation After Noncardiac Surgery and Stroke-Reply.
    JAMA. 2021;325:187-188.
    PubMed    


  75. HU SM, Fang XH, Li HF
    Postoperative Atrial Fibrillation After Noncardiac Surgery and Stroke.
    JAMA. 2021;325:187.
    PubMed    


  76. DIA A, Cifu AS, Shah AP
    Management of Patients With a Patent Foramen Ovale With History of Stroke or TIA.
    JAMA. 2021;325:81-82.
    PubMed    


    December 2020
  77. HARSHFIELD EL, Pennells L, Schwartz JE, Willeit P, et al
    Association Between Depressive Symptoms and Incident Cardiovascular Diseases.
    JAMA. 2020;324:2396-2405.
    PubMed     Abstract available


    October 2020
  78. BAIU I, Stern JR
    Carotid Artery Stenting.
    JAMA. 2020;324:1690.
    PubMed    


  79. YOU SC, Rho Y, Bikdeli B, Kim J, et al
    Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    JAMA. 2020;324:1640-1650.
    PubMed     Abstract available


  80. MAN S, Fonarow GC
    Door-to-Needle Time and Long-term Outcomes in Patients With Stroke-Reply.
    JAMA. 2020;324:1467-1468.
    PubMed    


  81. LI HF, Hu SM, Song HQ
    Door-to-Needle Time and Long-term Outcomes in Patients With Stroke.
    JAMA. 2020;324:1467.
    PubMed    


    September 2020
  82. BUTTGEREIT F, Matteson EL, Dejaco C
    Polymyalgia Rheumatica and Giant Cell Arteritis.
    JAMA. 2020;324:993-994.
    PubMed    


    June 2020
  83. HADAYA J, Benharash P
    Extracorporeal Membrane Oxygenation.
    JAMA. 2020;323:2536.
    PubMed    


    March 2020
  84. RAY KK, Nicholls SJ, Buhr KA, Ginsberg HN, et al
    Effect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes: A Randomized Clinical Trial.
    JAMA. 2020 Mar 27. pii: 2763951. doi: 10.1001/jama.2020.3308.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cerebrovascular Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: